.labour�s new study is based on freedom of information data from 95 english nhs trust (file pic)
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
.
.
.
.
.